跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml
Approved
STANDARD
MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
597e00880fef6d14
Company
Unknown
Type
Standard
Approval Details
Approval Id
597e00880fef6d14
Drug Name
MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 mg/5 ml
Active Ingredients
CLAVULANATE POTASSIUM EQV CLAVULANIC ACID
62.5 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
597e00880fef6d14
Type
Standard
Back to HSA Approvals
